SOURCE: StockCall


July 29, 2011 08:49 ET

Equity Research on Perrigo Co. and Auxilium Pharmaceuticals Inc. - Drug Related Products See Tailwinds

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jul 29, 2011) - offers investors comprehensive research on the Drug Related Products industry and has completed analytical research on Perrigo Co. (NASDAQ: PRGO) and Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL). Register with us today at to have free access to these researches.

Several factors have combined to create tailwinds for the Drug Related Products sector, especially those companies that market cheaper generic products. As the economy struggled and consumers looked for ways to rein in their budgets, companies marketing more towards the price-conscious consumer did well. Perrigo Co. which does a large amount of business through Wal-Mart stores is one company that has seen strong gains throughout the downturn and recovery. Perrigo Co. research report is accessible for free by registering today at is an online platform where investors doing their due-diligence on the Drug Related Products industry can have easy and free access to our analyst research and opinions on Perrigo Co. and Auxilium Pharmaceuticals Inc.; investors and shareholders of these companies can simply register for a complimentary membership at

Now, as the economy heads back towards a period of uncertainty, companies in what has generally been regarded as defensive health-care sector like Auxilium Pharmaceuticals Inc. could gain even more interest from investors. Auxilium Pharmaceuticals Inc. research report is available for free by signing up now at

Other major tailwinds that make the sector attractive are the many patent-expirations for major drugs looming in the near-future. While this will be bad news for brand-named drug manufacturers, the generic makers in the sector will have a whole new set of products to try and sell, representing a major opportunity for growth. In the meantime, many companies are looking to M&A to pad their pipelines. Register now at to have free access to our reports on the Drug Related Products industry.

About is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information